Literature DB >> 24401018

Single-cell gene expression analysis reveals clonal architecture of blast-phase chronic myeloid leukaemia.

Arika Nukina1, Yuki Kagoya, Naoko Watanabe-Okochi, Shunya Arai, Koki Ueda, Akihide Yoshimi, Yasuhito Nannya, Mineo Kurokawa.   

Abstract

Entities:  

Keywords:  BCR-ABL1; chronic myeloid leukaemia; chronic myeloid leukaemia stem cells; chronic myeloid leukaemia-blast crisis; single-cell

Mesh：

Year:  2014        PMID： 24401018     DOI： 10.1111/bjh.12726

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  4 in total

1.  RUNX1-ETO and RUNX1-EVI1 Differentially Reprogram the Chromatin Landscape in t(8;21) and t(3;21) AML.

Authors:  Justin Loke; Salam A Assi; Maria Rosaria Imperato; Anetta Ptasinska; Pierre Cauchy; Yura Grabovska; Natalia Martinez Soria; Manoj Raghavan; H Ruud Delwel; Peter N Cockerill; Olaf Heidenreich; Constanze Bonifer
Journal:  Cell Rep       Date:  2017-05-23       Impact factor: 9.423

2.  ADAM8 Is an Antigen of Tyrosine Kinase Inhibitor-Resistant Chronic Myeloid Leukemia Cells Identified by Patient-Derived Induced Pluripotent Stem Cells.

Authors:  Masashi Miyauchi; Junji Koya; Shunya Arai; Sho Yamazaki; Akira Honda; Keisuke Kataoka; Akihide Yoshimi; Kazuki Taoka; Keiki Kumano; Mineo Kurokawa
Journal:  Stem Cell Reports       Date:  2018-02-08       Impact factor: 7.765

Review 3.  Mechanisms of Disease Progression and Resistance to Tyrosine Kinase Inhibitor Therapy in Chronic Myeloid Leukemia: An Update.

Authors:  Luana Bavaro; Margherita Martelli; Michele Cavo; Simona Soverini
Journal:  Int J Mol Sci       Date:  2019-12-05       Impact factor: 5.923

4.  RUNX1-EVI1 disrupts lineage determination and the cell cycle by interfering with RUNX1 and EVI1 driven gene regulatory networks.

Authors:  Sophie G Kellaway; Peter Keane; Ella Kennett; Constanze Bonifer
Journal:  Haematologica       Date:  2021-06-01       Impact factor: 9.941
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.